Premium
TNF Nco‐I RFLP IS NOT AN INDEPENDENT RISK FACTOR IN RHEUMATOID ARTHRITIS
Author(s) -
Campbell D. A.,
Nelson S.,
Madhok R.,
Field M.,
Gallagher G.
Publication year - 1994
Publication title -
international journal of immunogenetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 47
eISSN - 1744-313X
pISSN - 1744-3121
DOI - 10.1111/j.1744-313x.1994.tb00219.x
Subject(s) - rheumatoid arthritis , allele , restriction fragment length polymorphism , immunology , haplotype , major histocompatibility complex , genetic predisposition , biology , tumor necrosis factor alpha , genetics , gene , genotype
SUMMARY The human TNF genes are located within the MHC class‐III region on chromosome 6. The presence or absence of an Nco‐I restriction site in the 5’ non‐coding sequence of the TNFβ gene defines two alleles (TNFB*1 and TNFB*2). The segregation of these alleles has been associated with levels of TNFα or TNFβ production in systemic lupus erythematosis (SLE), insulin‐dependent diabetes mellitus (IDDM) and in healthy control individuals. Rheumatoid arthritis (RA) is characterized by high levels of TNFα within the synovial fluid and to address the question of whether this could be brought about by a genetic predisposition to high TNF production by RA individuals, we examined the distribution of this Nco‐I polymorphism in 98 healthy volunteers and 123 patients with active rheumatoid arthritis. No difference was observed between the normal and RA groups with respect to haplotype segregation or allelic frequency. Furthermore, no difference was observed between DR4 + or DR4 ‐ individuals in the control or RA groups. These data demonstrate that the high level of TNFα seen in the joints of RA patients is unlikely to be due to a genetic predisposition of these patients to high TNFα production, as defined by the TNF Nco‐I restriction fragment length polymorphism (RFLP).